YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded...
Read More Details
Finally We wish PressBee provided you with enough information of ( Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths )
Also on site :
- This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?
- In Q1 2025, enterprise SaaS M&A deal count hit 210, according to PitchBook
- Walmart Is Selling an 'Absolutely Beautiful' $100 Jumpsuit for Just $20, and Shoppers Say It's 'Very Comfortable'